Katherine A Pratte1, Ann Johnson2, Janette Beals2, Ann Bullock3, Spero M Manson2, Luohua Jiang4. 1. Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, CA. 2. Centers for American Indian and Alaska Native Health, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO. 3. Division of Diabetes Treatment and Prevention, Indian Health Service, Rockville, MD. 4. Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, CA lhjiang@uci.edu.
Abstract
OBJECTIVE: This study evaluated whether regression from impaired glucose regulation (IGR) to normal glucose regulation (NGR) after 1 year of a lifestyle intervention reduces diabetes risk in American Indians and Alaska Natives (AI/ANs). In addition, we sought to identify predictors for regression to NGR and understand possible mechanisms for the association between NGR and future diabetes risk. RESEARCH DESIGN AND METHODS: Data from participants enrolled from 2006 to 2009 in the Special Diabetes Program for Indians Diabetes Prevention Program with IGR at baseline and an oral glucose tolerance test at year 1 were analyzed (N = 1,443). Cox regression models were used to estimate the subsequent diabetes risk (year 1 to year 3) by year 1 glucose status. Mediation analysis was used to estimate the proportions of the association between year 1 glycemic status and diabetes risk explained by specific factors. RESULTS: Those who reverted to NGR at year 1 (38%) had lower diabetes risk than those with sustained IGR (adjusted hazard ratio 0.28, 95% CI 0.12-0.67). The lower risk associated with regression to NGR was explained by both baseline risk factors and differences in weight loss. Metformin use, weight loss, and an increase in exercise were modifiable risk factors associated with higher odds of regression to NGR. CONCLUSIONS: Patients with prediabetes who reverted to NGR had a reduced risk of developing type 2 diabetes over the next 2 years. Both baseline and modifiable risk factors explained the risk reduction associated with NGR.
OBJECTIVE: This study evaluated whether regression from impaired glucose regulation (IGR) to normal glucose regulation (NGR) after 1 year of a lifestyle intervention reduces diabetes risk in American Indians and Alaska Natives (AI/ANs). In addition, we sought to identify predictors for regression to NGR and understand possible mechanisms for the association between NGR and future diabetes risk. RESEARCH DESIGN AND METHODS: Data from participants enrolled from 2006 to 2009 in the Special Diabetes Program for Indians Diabetes Prevention Program with IGR at baseline and an oral glucose tolerance test at year 1 were analyzed (N = 1,443). Cox regression models were used to estimate the subsequent diabetes risk (year 1 to year 3) by year 1 glucose status. Mediation analysis was used to estimate the proportions of the association between year 1 glycemic status and diabetes risk explained by specific factors. RESULTS: Those who reverted to NGR at year 1 (38%) had lower diabetes risk than those with sustained IGR (adjusted hazard ratio 0.28, 95% CI 0.12-0.67). The lower risk associated with regression to NGR was explained by both baseline risk factors and differences in weight loss. Metformin use, weight loss, and an increase in exercise were modifiable risk factors associated with higher odds of regression to NGR. CONCLUSIONS:Patients with prediabetes who reverted to NGR had a reduced risk of developing type 2 diabetes over the next 2 years. Both baseline and modifiable risk factors explained the risk reduction associated with NGR.
Authors: Leigh Perreault; Qing Pan; Kieren J Mather; Karol E Watson; Richard F Hamman; Steven E Kahn Journal: Lancet Date: 2012-06-09 Impact factor: 79.321
Authors: X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard Journal: Diabetes Care Date: 1997-04 Impact factor: 19.112
Authors: Miriam Cnop; Josep Vidal; Rebecca L Hull; Kristina M Utzschneider; Darcy B Carr; Todd Schraw; Philipp E Scherer; Edward J Boyko; Wilfred Y Fujimoto; Steven E Kahn Journal: Diabetes Care Date: 2007-03 Impact factor: 19.112
Authors: Tari D Topolski; James LoGerfo; Donald L Patrick; Barbara Williams; Julie Walwick; Marsha B Patrick Journal: Prev Chronic Dis Date: 2006-09-15 Impact factor: 2.830
Authors: Ronald B Goldberg; Marinella Temprosa; Steven Haffner; Trevor J Orchard; Robert E Ratner; Sarah E Fowler; Kieren Mather; Santica Marcovina; Chris Saudek; Margaret J Matulik; David Price Journal: Diabetes Care Date: 2009-01-26 Impact factor: 17.152
Authors: Kathryn R Koller; Gretchen E Day; Vanessa Y Hiratsuka; Julie A Beans; Sarah H Nash; Diana G Redwood; Jianhui Zhu; Barbara V Howard; Jason G Umans Journal: Diabetes Res Clin Pract Date: 2020-07-31 Impact factor: 5.602